Tasly Pharmaceutical Group Co., Ltd (600535.SS) SHH

15.81

-0.09(-0.57%)

Updated at October 20 11:19AM

Currency In CNY

Valuation

Market Cap21.59B
Enterprise Value19.62B
P/E Ratio22.1
PEG Ratio2.43
Price/Sales Ratio2.81
Price/Book Ratio1.91
Enterprise/Revenue2.59
Enterprise/EBITDA16.07

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.13
Operating Margin0.14

Management Effectiveness

Return On Assets0.07
Return On Equity0.09

Income Statement

Revenue8.5B
Revenue/Share5.63
Gross Profit5.69B
EBITDA1.83B
Net Income955.59M
Diluted EPS0.64

Balance Sheet

Total Cash4.23B
Total Cash/Share2.83
Total Debt983.73M
Total Debt/Equity0.08
Current Ratio3.31
Book Value Per Share8.43

Price History

52-Week Change2.93
52-Week High17.69
52-Week Low13.51
Moving Average 50 Days16.24
Moving Average 200 Days15.6

Statistics

Average Volume19.87M
Shares Outstanding1.49B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.41
Trailing Annual Dividend Yield2.59
Payout Ratio0.78
Last Split Factor7:5
Last Split DateJune 05, 2018